StonvexLoading…
StonvexStonvexStonvexCore line items from FHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.80B | $1.63B | $1.61B | $1.45B |
Operating Income | $513.88M | $361.47M | $387.55M | $336.80M |
Net Income | $403.30M | $268.31M | $298.98M | $239.50M |
EPS (Diluted) | $5.13 | $3.23 | $3.40 | $2.65 |
Total Assets | $2.23B | $2.08B | $2.10B | $2.02B |
Total Liabilities | $965.86M | $933.96M | $947.75M | $912.97M |
Cash & Equivalents | $582.54M | $504.44M | $383.18M | $336.78M |
Free Cash Flow OCF − CapEx | $294.58M | $342.53M | $303.92M | $319.58M |
Shares Outstanding | 75.10M | 79.43M | 83.86M | 85.77M |